BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 27878261)

  • 1. Bacterial ghosts as adjuvants in syngeneic tumour cell lysate-based anticancer vaccination in a murine lung carcinoma model.
    Kraśko JA; Žilionytė K; Darinskas A; Strioga M; Rjabceva S; Zalutsky I; Derevyanko M; Kulchitsky V; Lubitz W; Kudela P; Miseikyte-Kaubriene E; Karaman O; Didenko H; Potebnya H; Chekhun V; Pašukonienė V
    Oncol Rep; 2017 Jan; 37(1):171-178. PubMed ID: 27878261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-operative unadjuvanted therapeutic xenovaccination with chicken whole embryo vaccine suppresses distant micrometastases and prolongs survival in a murine Lewis lung carcinoma model.
    Kraśko JA; Žilionytė K; Darinskas A; Dobrovolskienė N; Mlynska A; Riabceva S; Zalutsky I; Derevyanko M; Kulchitsky V; Karaman O; Fedosova N; Symchych TV; Didenko G; Chekhun V; Strioga M; Pašukonienė V
    Oncol Lett; 2018 Apr; 15(4):5098-5104. PubMed ID: 29552144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma.
    Wu A; Oh S; Gharagozlou S; Vedi RN; Ericson K; Low WC; Chen W; Ohlfest JR
    J Immunother; 2007; 30(8):789-97. PubMed ID: 18049330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient responses in a murine renal tumor model by electroloading dendritic cells with whole-tumor lysate.
    Weiss JM; Allen C; Shivakumar R; Feller S; Li LH; Liu LN
    J Immunother; 2005; 28(6):542-50. PubMed ID: 16224271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination with TCL plus MHSP65 induces anti-lung cancer immunity in mice.
    Dong B; Sun L; Wu X; Zhang P; Wang L; Wei H; Zhou L; Hu X; Yu Y; Hua S; Wang L
    Cancer Immunol Immunother; 2010 Jun; 59(6):899-908. PubMed ID: 20087582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superior anti-tumor protection and therapeutic efficacy of vaccination with dendritic cell/tumor cell fusion hybrids for murine Lewis lung carcinoma.
    Chen X; Liu Z; Huang Y; Li R; Zhang H; Dong S; Ge C; Zhang Z; Wang Y; Wang Y; Xue Y; Li Z; Song X
    Autoimmunity; 2014 Feb; 47(1):46-56. PubMed ID: 24191684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination with FasL-/TCL plus MHSP65 induces improved anti-lung cancer immunity in mice.
    Dong B; Dai G; Ding Y; Wang B; Zhang S
    Int Immunopharmacol; 2018 Feb; 55():306-311. PubMed ID: 29310106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic immunotherapy by intrapleural, intraperitoneal and subcutaneous injection of IL-2 gene-modified Lewis lung carcinoma cells.
    Heike Y; Takahashi M; Ohira T; Naruse I; Hama S; Ohe Y; Kasai T; Fukumoto H; Olsen KJ; Podack EE; Saijo N
    Int J Cancer; 1997 Dec; 73(6):844-9. PubMed ID: 9399664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of murine Lewis lung cancer with recombinant interleukin-12].
    Yin XL; Duan H; Peng ZP; Sun SL; Li SL
    Ai Zheng; 2006 Sep; 25(9):1087-91. PubMed ID: 16965647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocyte-macrophage colony-stimulating factor gene-transduced tumor cells combined with tumor-derived gp96 inhibit tumor growth in mice.
    Kojima T; Yamazaki K; Tamura Y; Ogura S; Tani K; Konishi J; Shinagawa N; Kinoshita I; Hizawa N; Yamaguchi E; Dosaka-Akita H; Nishimura M
    Hum Gene Ther; 2003 May; 14(8):715-28. PubMed ID: 12804136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumour responses induced by a cell-based Reovirus vaccine in murine lung and melanoma models.
    Campion CA; Soden D; Forde PF
    BMC Cancer; 2016 Jul; 16():462. PubMed ID: 27412241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Allogeneic dendritic cell vaccine pulsed with heat shocked tumor cell lysate can enhance antitumor immunity].
    You J; Wang CL; Hao XS
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2785-90. PubMed ID: 18167273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Particle-size-dependent toxicity and immunogenic activity of mesoporous silica-based adjuvants for tumor immunotherapy.
    Wang X; Li X; Ito A; Sogo Y; Ohno T
    Acta Biomater; 2013 Jul; 9(7):7480-9. PubMed ID: 23541601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysates of S. pyogenes serotype M49 induce pancreatic tumor growth delay by specific and unspecific antitumor immune responses.
    Linnebacher M; Maletzki C; Emmrich J; Kreikemeyer B
    J Immunother; 2008 Oct; 31(8):704-13. PubMed ID: 18779749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic Dendritic Cell-Based Vaccines Efficiently Inhibit Metastases in Murine Metastatic Melanoma.
    Markov OV; Mironova NL; Sennikov SV; Vlassov VV; Zenkova MA
    PLoS One; 2015; 10(9):e0136911. PubMed ID: 26325576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant autologous tumour cell-lysate vaccine versus no adjuvant treatment in patients with M0 renal cell carcinoma after radical nephrectomy: 3-year interim analysis of a German multicentre phase-III trial.
    Doehn Ch; Richter A; Lehmacher W; Jocham D
    Folia Biol (Praha); 2003; 49(2):69-73. PubMed ID: 12779015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination with allogeneic GM-CSF gene-modified lung cancer cells: antitumor activity comparing with that induced by autologous vaccine.
    Li H; Jiang HJ; Ma MQ; Wei F; An XM; Ren XB
    Cancer Biother Radiopharm; 2007 Dec; 22(6):790-8. PubMed ID: 18158770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of spontaneous metastatic lung cancer with tumor antigen-pulsed, interleukin-18 gene-modified dendritic cells].
    Chen J; Cao X; Xiu Q
    Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(13):779-82. PubMed ID: 11798964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of murine Lewis lung carcinoma metastases by combined chemotherapy and intranasal THF-gamma 2 immunotherapy.
    Rashid G; Ophir R; Pecht M; Lourie S; Meshorer A; Ben-Efraim S; Trainin N; Burstein Y; Keisari Y
    J Immunother Emphasis Tumor Immunol; 1996 Sep; 19(5):324-33. PubMed ID: 8941872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic cancer immunotherapy using a tumor lysate vaccine, engineered to express α-gal epitopes, targets pancreatic cancer stem cells.
    Tanida T; Tanemura M; Miyoshi E; Nagano H; Furukawa K; Nonaka Y; Akita H; Hama N; Wada H; Kawamoto K; Kobayashi S; Eguchi H; Mori M; Doki Y
    Int J Oncol; 2015 Jan; 46(1):78-90. PubMed ID: 25354268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.